Last update:

Oncology news

How we are engineering bacteria to eat cancer

Modern medicine has made significant advances in cancer treatments over the decades. But all cancer therapies still face one critical challenge: how to target cancers without damaging healthy cells.

New tool makes immune therapy more effective in prostate cancer

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy new life, improving its ...

Cancer clinicians welcome AI that supports human expertise

Artificial intelligence is often presented as a threat to professional work, raising fears about deskilling, job displacement and the loss of human judgment. But new research involving health care professionals using AI in ...

New cancer drug shows promise in mesothelioma trial

Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about ...

For your health—can your breakfast help lower cancer risk?

Don't sleep on the cancer prevention benefits of a healthy breakfast. Whether it's oatmeal, whole-wheat toast, berries in Greek yogurt or other healthy combinations—starting the morning with simple, whole foods is a great ...

Immunotherapy shows long-term promise in aggressive lymphoma

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...

KRAS-targeting drugs show promise for rare appendix cancer

Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.